Steffen Ormanns

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Topics

Metastatic Colorectal Cancer

Direct Oral Anticoagulants

Venous Thromboembolism

Top Venues

JCO precision oncology

British journal of cancer

Cancer immunology, immunotherapy : CII

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Kathrin Heinrich, Laura E Fischer, Enrico N De Toni, Daniel Markwardt, Daniel Roessler, Georg Beyer, Michael Günther, Steffen Ormanns, Frederick Klauschen, Wolfgang Gerhard Kunz, Stefan Fröhling, Tilman Brummer, Volker Heinemann, Christoph Benedikt Westphalen
Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy. JCO precision oncology 7 (2023)
Manuela Thienel, Johannes B Müller, Zhe Zhang, Vincent Ehreiser, Judith Huth, Khrystyna Shchurovska, Badr Kilani, Lisa Schweizer, Philipp E Geyer, Maximilian Zwiebel, Julia Novotny, Enzo Lüsebrink, Gemma Little, Martin Orban, Leo Nicolai, Shaza El Nemr, Anna Titova, Michael Spannagl, Jonas Kindberg, Alina L Evans, Orpheus Mach, Matthias Vogel, Steffen Tiedt, Steffen Ormanns, Barbara Kessler, Anne Dueck, Andrea Friebe, Peter Godsk Jørgensen, Monir Majzoub-Altweck, Andreas Blutke, Amin Polzin, Konstantin Stark, Stefan Kääb, Doris Maier, Jonathan M Gibbins, Ulrich Limper, Ole Fröbert, Matthias Mann, Steffen Massberg, Tobias Petzold
Immobility-associated thromboprotection is conserved across mammalian species from bear to human. Science (New York, N.Y.) 380 (6641) (2023)
Michael Guenther, Sai Agash Surendran, Michael Haas, Volker Heinemann, Michael von Bergwelt-Baildon, Jutta Engel, Jens Werner, Stefan Boeck, Steffen Ormanns
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer. British journal of cancer (2023)
Kathrin Heinrich, Laura E Fischer, Enrico N De Toni, Daniel Markwardt, Daniel Roessler, Georg Beyer, Michael Günther, Steffen Ormanns, Frederick Klauschen, Wolfgang Gerhard Kunz, Stefan Fröhling, Tilman Brummer, Volker Heinemann, Christoph Benedikt Westphalen
Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy. JCO precision oncology 7 (2023)
Kathrin Heinrich, Laura E Fischer, Enrico N De Toni, Daniel Markwardt, Daniel Roessler, Georg Beyer, Michael Günther, Steffen Ormanns, Frederick Klauschen, Wolfgang Gerhard Kunz, Stefan Fröhling, Tilman Brummer, Volker Heinemann, Christoph Benedikt Westphalen
Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy. JCO precision oncology 7 (2023)
Michael Guenther, Lina Gil, Sai Agash Surendran, Melanie Alexandra Palm, Volker Heinemann, Michael von Bergwelt-Baildon, Julia Mayerle, Jutta Engel, Jens Werner, Stefan Boeck, Steffen Ormanns
Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic Cancer. JNCI cancer spectrum 6 (3) (2022)
Michael Guenther, Stefan Boeck, Volker Heinemann, Jens Werner, Jutta Engel, Steffen Ormanns
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer. International journal of cancer 151 (6) (2022)
Philipp Metzger, Sabrina V Kirchleitner, Daniel F R Boehmer, Christine Hörth, Angelika Eisele, Steffen Ormanns, Matthias Gunzer, Maciej Lech, Kirsten Lauber, Stefan Endres, Peter Duewell, Max Schnurr, Lars M Koenig
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model. Cancer immunology, immunotherapy : CII 69 (10) (2020)
Michael Guenther, Michael Haas, Volker Heinemann, Stephan Kruger, Christoph Benedikt Westphalen, Michael von Bergwelt-Baildon, Julia Mayerle, Jens Werner, Thomas Kirchner, Stefan Boeck, Steffen Ormanns
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study. British journal of cancer 123 (9) (2020)
Michael Guenther, Vivien Veninga, Joerg Kumbrink, Michael Haas, C Benedikt Westphalen, Stephan Kruger, Volker Heinemann, Thomas Kirchner, Stefan Boeck, Andreas Jung, Steffen Ormanns
POLE gene hotspot mutations in advanced pancreatic cancer. Journal of cancer research and clinical oncology 144 (11) (2018)
Sibylle Baechmann, Steffen Ormanns, Michael Haas, Stephan Kruger, Anna Remold, Dominik Paul Modest, Thomas Kirchner, Andreas Jung, Jens Werner, Volker Heinemann, Stefan Boeck
Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research. BMC cancer 17 (1) (2017)